Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Six-month, Open Labeled, Multi-centered, Observational Study for the Tolerability of Exelon Patch (Rivastigmine) for Patients With Alzheimer's Disease

NCT01312363 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01312363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01312363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Six-month, Open Labeled, Multi-centered, Observational Study for the Tolerability of Exelon Patch (Rivastigmine) for Patients With Alzheimer's Disease
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2011
Enrollment
300 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease